BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8889080)

  • 1. Health beliefs and compliance with antipsychotic medication.
    Budd RJ; Hughes IC; Smith JA
    Br J Clin Psychol; 1996 Sep; 35(3):393-7. PubMed ID: 8889080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight.
    Garavan J; Browne S; Gervin M; Lane A; Larkin C; O'Callaghan E
    Compr Psychiatry; 1998; 39(4):215-9. PubMed ID: 9675506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a structural model explaining medication compliance of persons with schizophrenia.
    Seo MA; Min SK
    Yonsei Med J; 2005 Jun; 46(3):331-40. PubMed ID: 15988803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postdischarge medication compliance of inpatients converted from an oral to a depot neuroleptic regimen.
    Weiden P; Rapkin B; Zygmunt A; Mott T; Goldman D; Frances A
    Psychiatr Serv; 1995 Oct; 46(10):1049-54. PubMed ID: 8829787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative symptoms of schizophrenia and compliance with medication.
    Tattan TM; Creed FH
    Schizophr Bull; 2001; 27(1):149-55. PubMed ID: 11215543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
    Stanković Z; Britvić D; Vuković O; Ille T
    Psychiatr Danub; 2008 Mar; 20(1):42-52. PubMed ID: 18376330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug compliance and health locus of control in schizophrenia].
    Combes C; Feral F
    Encephale; 2011 May; 37 Suppl 1():S11-8. PubMed ID: 21600328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication adherence studies in schizophrenia.
    Hogarty GE
    Am J Psychiatry; 2004 Mar; 161(3):581-2; author reply 582-3. PubMed ID: 14992994
    [No Abstract]   [Full Text] [Related]  

  • 10. Medication adherence studies in schizophrenia.
    Hamann J; Pitschel-Walz G; Kissling W
    Am J Psychiatry; 2004 Mar; 161(3):582; author reply 582-3. PubMed ID: 14992997
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis.
    Donohoe G; Owens N; O'Donnell C; Burke T; Moore L; Tobin A; O'Callaghan E
    Eur Psychiatry; 2001 Aug; 16(5):293-8. PubMed ID: 11514132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.
    Löffler W; Kilian R; Toumi M; Angermeyer MC
    Pharmacopsychiatry; 2003 May; 36(3):105-12. PubMed ID: 12806568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Patient modified medication: how do schizophrenic patients manage their neuroleptics?].
    Hornung WP; Buchkremer G; Redbrake M; Klingberg S
    Nervenarzt; 1993 Jul; 64(7):434-9. PubMed ID: 8103569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of interventions to improve compliance with antipsychotic medication in people suffering from schizophrenia-results of recent reviews].
    Puschner B; Born A; Giessler A; Helm H; Becker T; Angermeyer MC
    Psychiatr Prax; 2005 Mar; 32(2):62-7. PubMed ID: 15712037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term psychiatric patients' knowledge about their medication.
    Tempier R
    Psychiatr Serv; 1996 Dec; 47(12):1385-7. PubMed ID: 9117480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual reality assessment of medication compliance in patients with schizophrenia.
    Baker EK; Kurtz MM; Astur RS
    Cyberpsychol Behav; 2006 Apr; 9(2):224-9. PubMed ID: 16640484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial compliance with antipsychotic medication is common in patients with schizophrenia.
    Rummel-Kluge C; Schuster T; Peters S; Kissling W
    Aust N Z J Psychiatry; 2008 May; 42(5):382-8. PubMed ID: 18473256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.
    Kao YC; Liu YP
    Compr Psychiatry; 2010; 51(6):557-65. PubMed ID: 20965300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is interval medication a successful treatment regimen for schizophrenic patients with critical attitudes towards treatment?
    Godemann F; Linden M; Gaebel W; Köpke W; Müller P; Müller-Spahn F; Tegeler J; Pietzcker A
    Eur Psychiatry; 2003 Mar; 18(2):82-4. PubMed ID: 12711404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes towards neuroleptic treatment: reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire.
    Kampman O; Lehtinen K; Lassila V; Leinonen E; Poutanen O; Koivisto A
    Schizophr Res; 2000 Oct; 45(3):223-34. PubMed ID: 11042440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.